Vivjoa (oteseconazole) — Blue Cross Blue Shield of Illinois

Initial criteria

• ALL of the following:
• The member resides in Ohio AND the plan is Fully Insured or HIM Shop (SG) AND the patient does NOT have any FDA labeled contraindications to the requested agent AND ONE of the following:
• the patient has another FDA labeled indication for the requested agent and route of administration OR the patient has another compendia-supported indication for the requested agent and route of administration OR the prescriber has submitted TWO articles from major peer-reviewed professional medical journals (e.g., JAMA, NEJM, Lancet) supporting the proposed use(s) as generally safe and effective, using acceptable study designs such as randomized, double-blind, placebo-controlled clinical trials (case studies not acceptable)

Approval duration

12 months